Pharmaceutical Litigation
- Medication injury claims,
- Adverse drug reactions,
- Long-term complications,
- Drug interaction injuries.
Mass Tort Clinical Intelligence
Structured Medical Record Review for Large-Scale Litigation
Lexcura Summit provides clinician-led mass tort medical record review for litigation teams managing large claimant populations, product liability claims, pharmaceutical matters, medical device cases, and exposure-related injuries.
Mass Tort Review Requires More Than File-by-File Summarization
Large-scale litigation requires disciplined claim screening, exposure verification, injury confirmation, causation analysis, and escalation logic. Lexcura structures medical records into usable clinical intelligence so legal teams can identify stronger files, eliminate weak claims, and prepare higher-value matters for expert review.
Core value: Lexcura helps litigation teams see claimant strength, medical proof, causation risk, and portfolio value before major expert or discovery spend.
Mass Tort Litigation
Mass Tort Litigation We Support
Traditional record review organizes information. Clinical Intelligence interprets that information within the clinical and legal context, helping attorneys understand not only what happened—but why it matters.
Medical Device Litigation
- Device failure,
- Migration or Fracture,
- Revision Surgery,
- Implant Infection.
Toxic Exposure
- Chemical Exposure,
- Contaminated Water,
- Occupational Hazards,
- Latency Analysis.
Product Liability
- Defective products,
- Cosmetic Injuries,
- Contaminated Products,
- Medical Complications.
The Mass Tort Workflow
Six Steps From Medical Records to Actionable Litigation Intelligence
Lexcura's structured workflow transforms complex claimant records into organized clinical intelligence, helping litigation teams evaluate exposure, injury, causation, and claim strength at scale.
- 1
Record Ingestion
Collect, normalize, organize, and quality-check claimant records.
- 2
Exposure Mapping
Confirm product use, timing, duration, provider involvement, and exposure history.
- 3
Injury Verification
Identify documented diagnoses, findings, treatment patterns, and injury consistency.
- 4
Causation Analysis
Evaluate temporal relationship, confounders, alternative causes, and medical plausibility.
- 5
Claimant Classification
Sort files by strength, review priority, litigation fit, and escalation need.
- 6
Bellwether / Expert Escalation
Advance stronger files for expert review, bellwether consideration, and deeper strategy.
Tiered Claimant Review
Eligibility Screening
High-volume screening to confirm exposure documentation, diagnosis, preliminary timeline markers, and record sufficiency.
Core Clinical Record Analysis
Structured review of exposure timeline, diagnosis, chronology, confounders, and preliminary causation.
Comprehensive Case Analysis
Detailed chronology, exposure analysis, alternative etiology review, causation assessment, and expert issue identification.
Defence Playbook
Defence Strategy & Mass Tort
Mass tort files are vulnerable when exposure, injury, timing, and causation are not clinically organized. Lexcura helps litigation teams anticipate and counter predictable defense themes.
Common Defense Arguments
- - "The product did not cause the injury"
- - "Claimants are too inconsistent."
- - "Preexisting conditions explain the injury."
- - "There is no temporal link."
Lexcura Clinical Intelligence Response
- - Lexcura maps exposure, timing, diagnosis, confounders, and medical plausibility to evaluate support for the injury theory.
- - Population-level review distinguishes meaningful variation from recurring clinical patterns.
- - Baseline analysis separates prior health status from post-exposure clinical change.
- - Chronology reconstruction clarifies whether the documented timeline supports causation.
Consistent review, individual evidence
Screen at scale without losing the claimant’s clinical story.
Portfolio review can reveal patterns and priorities, but each claimant still needs their own exposure documentation, injury support, and causation assessment. Screening criteria should be explicit and consistently applied.
01
What establishes this claimant’s exposure?
Identify the product, use dates, duration, and relevant records. Prescribing, dispensing, implantation, and actual use may be different facts. An incomplete record should not silently become either confirmed exposure or exclusion.
In practice · what this means for the case
Maintain confirmed, uncertain, and missing evidence separately. Counsel determines legal eligibility and any proceeding-specific requirements.
02
Is the claimed injury supported at the individual level?
Compare reported symptoms with diagnoses, imaging or test findings, treatment, onset, and baseline conditions. Similar labels can conceal meaningful differences in severity, mechanism, or clinical course.
In practice · what this means for the case
Apply common review fields while preserving individual exceptions. A diagnosis code alone may not resolve the clinical question.
03
Which files need clarification or specialist escalation?
Prioritise material gaps, uncertain timing, competing causes, unusual presentations, and records that challenge the proposed association. Group-level patterns do not establish an individual causal connection.
In practice · what this means for the case
Use consistent reasons for escalation and revisit classifications when new evidence arrives. A preliminary screen is not a final causation opinion or a promise of recovery.
Illustrative scenario · not a client case
Illustrative claimant comparison
Two files list the same diagnosis after product use. One contains documented exposure and a clear symptom timeline; the other has uncertain use dates and a relevant pre-existing condition. The same diagnosis does not justify the same classification without investigating those differences.
A useful portfolio discussion explains the criteria, the uncertainty within each group, and which next evidence request could change a claimant’s review priority.
For the underlying methodology, see Clinical Intelligence. General educational information; conclusions about an individual matter require record-specific review.